Predictors of starting antimicrobial treatment in patients with nontuberculous mycobacterial lung disease in the Italian scenario: A SITA GIOVANI-IRENE promoted web-survey

Andrea Lombardi; M. Colaneri; M. Sambo; A. Di Matteo; P. Sacchi; M. Fabbiani; L. Codecasa; S. Aliberti; F. Blasi; A. Bandera; R. Bruno; A. Gori

doi:10.1016/j.rmed.2021.106341

Predictors of starting antimicrobial treatment in patients with nontuberculous mycobacterial lung disease in the Italian scenario: A SITA GIOVANI-IRENE promoted web-survey

Andrea Lombardi, M. Colaneri, M. Sambo, A. Di Matteo, P. Sacchi, M. Fabbiani, L. Codecasa, S. Aliberti, F. Blasi, A. Bandera, R. Bruno, A. Gori

Research output: Contribution to journal › Article › peer-review

Abstract

The disease burden due to nontuberculous mycobacteria is growing worldwide, consequently to improved diagnostic abilities and an increase in the individuals at risk. Uncertainties exist about the right moment on which start treatment. We investigated the clinical features associated with starting an antimicrobial treatment in patients with nontuberculous mycobacterial lung disease among Italian physicians involved in the field. We found that in real life predictors of starting antimicrobial treatment are quite adherent to international guidelines, with some uncertainties regarding the implication of immunosuppressive drugs. © 2021 Elsevier Ltd

Original language	English
Article number	106341
Journal	Respiratory Medicine
Volume	179
DOIs	https://doi.org/10.1016/j.rmed.2021.106341
Publication status	Published - 2021

Access to Document

10.1016/j.rmed.2021.106341

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101349598&doi=10.1016%2fj.rmed.2021.106341&partnerID=40&md5=09390affe969fec63d9d41371a79a39b

Cite this

Lombardi, A., Colaneri, M., Sambo, M., Di Matteo, A., Sacchi, P., Fabbiani, M., Codecasa, L., Aliberti, S., Blasi, F., Bandera, A., Bruno, R., & Gori, A. (2021). Predictors of starting antimicrobial treatment in patients with nontuberculous mycobacterial lung disease in the Italian scenario: A SITA GIOVANI-IRENE promoted web-survey. Respiratory Medicine, 179, [106341]. https://doi.org/10.1016/j.rmed.2021.106341

Lombardi, A, Colaneri, M, Sambo, M, Di Matteo, A , Sacchi, P, Fabbiani, M, Codecasa, L, Aliberti, S, Blasi, F, Bandera, A , Bruno, R & Gori, A 2021, 'Predictors of starting antimicrobial treatment in patients with nontuberculous mycobacterial lung disease in the Italian scenario: A SITA GIOVANI-IRENE promoted web-survey', Respiratory Medicine, vol. 179, 106341. https://doi.org/10.1016/j.rmed.2021.106341

@article{dd198fd97655429db91113f02fed0fc8,

title = "Predictors of starting antimicrobial treatment in patients with nontuberculous mycobacterial lung disease in the Italian scenario: A SITA GIOVANI-IRENE promoted web-survey",

abstract = "The disease burden due to nontuberculous mycobacteria is growing worldwide, consequently to improved diagnostic abilities and an increase in the individuals at risk. Uncertainties exist about the right moment on which start treatment. We investigated the clinical features associated with starting an antimicrobial treatment in patients with nontuberculous mycobacterial lung disease among Italian physicians involved in the field. We found that in real life predictors of starting antimicrobial treatment are quite adherent to international guidelines, with some uncertainties regarding the implication of immunosuppressive drugs. {\textcopyright} 2021 Elsevier Ltd",

author = "Andrea Lombardi and M. Colaneri and M. Sambo and {Di Matteo}, A. and P. Sacchi and M. Fabbiani and L. Codecasa and S. Aliberti and F. Blasi and A. Bandera and R. Bruno and A. Gori",

year = "2021",

doi = "10.1016/j.rmed.2021.106341",

language = "English",

volume = "179",

journal = "Respiratory Medicine",

issn = "0954-6111",

publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Predictors of starting antimicrobial treatment in patients with nontuberculous mycobacterial lung disease in the Italian scenario: A SITA GIOVANI-IRENE promoted web-survey

AU - Lombardi, Andrea

AU - Colaneri, M.

AU - Sambo, M.

AU - Di Matteo, A.

AU - Sacchi, P.

AU - Fabbiani, M.

AU - Codecasa, L.

AU - Aliberti, S.

AU - Blasi, F.

AU - Bandera, A.

AU - Bruno, R.

AU - Gori, A.

PY - 2021

Y1 - 2021

N2 - The disease burden due to nontuberculous mycobacteria is growing worldwide, consequently to improved diagnostic abilities and an increase in the individuals at risk. Uncertainties exist about the right moment on which start treatment. We investigated the clinical features associated with starting an antimicrobial treatment in patients with nontuberculous mycobacterial lung disease among Italian physicians involved in the field. We found that in real life predictors of starting antimicrobial treatment are quite adherent to international guidelines, with some uncertainties regarding the implication of immunosuppressive drugs. © 2021 Elsevier Ltd

AB - The disease burden due to nontuberculous mycobacteria is growing worldwide, consequently to improved diagnostic abilities and an increase in the individuals at risk. Uncertainties exist about the right moment on which start treatment. We investigated the clinical features associated with starting an antimicrobial treatment in patients with nontuberculous mycobacterial lung disease among Italian physicians involved in the field. We found that in real life predictors of starting antimicrobial treatment are quite adherent to international guidelines, with some uncertainties regarding the implication of immunosuppressive drugs. © 2021 Elsevier Ltd

U2 - 10.1016/j.rmed.2021.106341

DO - 10.1016/j.rmed.2021.106341

M3 - Article

SN - 0954-6111

VL - 179

JO - Respiratory Medicine

JF - Respiratory Medicine

M1 - 106341

ER -

Predictors of starting antimicrobial treatment in patients with nontuberculous mycobacterial lung disease in the Italian scenario: A SITA GIOVANI-IRENE promoted web-survey

Abstract

Access to Document

Fingerprint

Cite this